When:
September 26, 2018 @ 12:00 pm – 1:00 pm America/Chicago Timezone
2018-09-26T12:00:00-05:00
2018-09-26T13:00:00-05:00
Contact:
Jayme Steig, PharmD
701/989-6224

Medication_bottles
Presentation Handout

Only 20% of people with opioid use disorder receive treatment. The Centers for Medicare & Medicaid Services (CMS) Roadmap to Address the Opioid Epidemic lists expanding access to treatment as a key area of focus.

This webinar will offer the perspective of a physician dedicated to treating opioid use disorder. Topics to be discussed include: impact of opioid addiction, overview of Medication Assisted Treatment (MAT) and understanding benefits of MAT.

Target Audience:

Clinics, hospitals, pharmacies, home health, hospice, public health, consumers and families, and all community partners who will benefit from a discussion addressing medication assisted treatment.

Objectives:

Upon completion of this webinar, participants will be able to:

  1. Understand impact of opioid addiction
  2. Define medication assisted treatment (MAT)
  3. Identify medication used in treatment of opioid use disorder
  4. Discuss benefits of MAT and how to address associated stigmas

Presenter:

Melissa_Henke_MDMelissa J. Henke, MD
Medical Director
Heartview Foundation
Bismarck, ND

 

Dr. Henke, Board Certified in Internal Medicine and Psychiatry, serves as Heartview’s Medical Director. In that capacity, Dr. Henke participates in interdisciplinary case review, develops and oversees patient medical protocols, reviews nursing assessments for appropriate withdrawal management, and confers with the interdisciplinary team regarding patient care management. She also provides medical oversight to the Medication-Assisted Therapy program and ongoing care to individual patients.